000			01511 a2200445 4500
005			20250513112629.0
264		0	_c19970320
008			199703s 0 0 eng d
022			_a1074-7613
024	7		_a10.1016/s1074-7613(00)80421-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aBain, G
245	0	0	_aBoth E12 and E47 allow commitment to the B cell lineage. _h[electronic resource]
260			_bImmunity _cFeb 1997
300			_a145-54 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aDNA-Binding Proteins _xbiosynthesis
650	0	4	_aDrug Synergism
650	0	4	_aGene Rearrangement, B-Lymphocyte _xgenetics
650	0	4	_aMice
650	0	4	_aMice, Mutant Strains
650	0	4	_aMice, Transgenic
650	0	4	_aTCF Transcription Factors
650	0	4	_aTranscription Factor 7-Like 1 Protein
650	0	4	_aTranscription Factors _xbiosynthesis
650	0	4	_aTranscription, Genetic _xgenetics
700	1		_aRobanus Maandag, E C
700	1		_ate Riele, H P
700	1		_aFeeney, A J
700	1		_aSheehy, A
700	1		_aSchlissel, M
700	1		_aShinton, S A
700	1		_aHardy, R R
700	1		_aMurre, C
773	0		_tImmunity _gvol. 6 _gno. 2 _gp. 145-54
856	4	0	_uhttps://doi.org/10.1016/s1074-7613(00)80421-5 _zAvailable from publisher's website
999			_c9035635 _d9035635